MESP1 | Mesoderm posterior basic helix-loop-helix transcription factor 1 | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/10689/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10689/151953_B_6_7_rna_selected_60x60.jpg) | Group enriched |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/16662/ihc_cell_selected_60x60.jpg) | ![](/images/16662/37497_B_7_1_rna_selected_60x60.jpg) | Group enriched |
SLC7A10 | Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 | Predicted membrane proteins Transporters
| ![](/images/41884/ihc_selected_60x60.jpg) | ![](/images/41884/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41884/87774_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
THRSP | Thyroid hormone responsive | Predicted intracellular proteins
| ![](/images/40642/ihc_selected_60x60.jpg) | ![](/images/40642/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40642/90389_B_8_1_rna_selected_60x60.jpg) | Group enriched |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/3596/ihc_cell_selected_60x60.jpg) | ![](/images/3596/11016_B_9_3_rna_selected_60x60.jpg) | Group enriched |
AOC2 | Amine oxidase, copper containing 2 (retina-specific) | Enzymes Predicted secreted proteins
| ![](/images/57779/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57779/133414_B_8_2_rna_selected_60x60.jpg) | Group enriched |
AQP7 | Aquaporin 7 | Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/14044/if_selected_60x60.jpg) | ![](/images/14044/ihc_cell_selected_60x60.jpg) | ![](/images/3789/10114_B_2_1_rna_selected_60x60.jpg) | Group enriched |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | ![](/images/6461/155193_B_7_1_rna_selected_60x60.jpg) | Tissue enriched |
FFAR4 | Free fatty acid receptor 4 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/42563/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42563/95411_B_9_1_rna_selected_60x60.jpg) | Group enriched |
FP325317.1 | | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
GHR | Growth hormone receptor | Disease related genes FDA approved drug targets Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
LBP | Lipopolysaccharide binding protein | Plasma proteins Predicted secreted proteins Transporters
| ![](/images/1508/ihc_selected_60x60.jpg) | ![](/images/1508/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/1508/4957_B_7_5_rna_selected_60x60.jpg) | Group enriched |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
NNAT | Neuronatin | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
RAD51L3-RFFL | HCG2039718, isoform CRA_g {ECO:0000313|EMBL:EAW80179.1}; Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000466834} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/55550/878_A7_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SLC29A4 | Solute carrier family 29 (equilibrative nucleoside transporter), member 4 | Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
THBS4 | Thrombospondin 4 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images/4597/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/4597/ihc_cell_selected_60x60.jpg) | ![](/images/4597/42983_B_9_1_rna_selected_60x60.jpg) | Group enriched |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| ![](/images/40336/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40336/86733_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| ![](/images/42867/ihc_selected_60x60.jpg) | ![](/images/42867/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42867/95746_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Cancer-related genes Enzymes Predicted intracellular proteins
| ![](/images/25876/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25876/57533_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/29679/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29678/70371_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
AL109927.1 | HCG2032222 {ECO:0000313|EMBL:EAX07737.1}; PRO2047 {ECO:0000313|EMBL:AAF22035.1} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images/28472/1296_D7_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ANGPT4 | Angiopoietin 4 | Predicted secreted proteins RAS pathway related proteins
| ![](/images/13260/ihc_selected_60x60.jpg) | ![](/images/13305/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13260/28493_B_3_6_rna_selected_60x60.jpg) | Tissue enhanced |
ANGPTL4 | Angiopoietin-like 4 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images/33770/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33770/152718_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
APOD | Apolipoprotein D | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
APOLD1 | Apolipoprotein L domain containing 1 | Predicted membrane proteins
| ![](/images/52462/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/52462/122619_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
ARHGEF15 | Rho guanine nucleotide exchange factor (GEF) 15 | Predicted intracellular proteins
| ![](/images/44443/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44443/99613_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
ATOH8 | Atonal homolog 8 (Drosophila) | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
BOK | BCL2-related ovarian killer | Plasma proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
BTNL9 | Butyrophilin-like 9 | Predicted membrane proteins
| ![](/images/43429/ihc_selected_60x60.jpg) | ![](/images/43429/1472_B9_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/43429/95031_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
C1QTNF1 | C1q and tumor necrosis factor related protein 1 | Predicted intracellular proteins Predicted secreted proteins
| ![](/images/25429/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25429/58767_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
C1QTNF5 | C1q and tumor necrosis factor related protein 5 | Disease related genes Predicted secreted proteins
| ![](/images/25607/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25607/56893_A_5_7_rna_selected_60x60.jpg) | Tissue enhanced |
C2CD4B | C2 calcium-dependent domain containing 4B | Predicted intracellular proteins
| ![](/images/46880/ihc_selected_60x60.jpg) | ![](/images/46880/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/46880/105674_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
C2orf66 | Chromosome 2 open reading frame 66 | Predicted secreted proteins
| ![](/images/20869/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/20869/48128_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/7305/18323_B_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
CCL18 | Chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | Cancer-related genes Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CD248 | CD248 molecule, endosialin | CD markers Predicted membrane proteins
| ![](/images/51856/ihc_selected_60x60.jpg) | ![](/images/51856/1368_F10_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/51856/120430_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CD300LG | CD300 molecule-like family member g | CD markers Predicted membrane proteins Predicted secreted proteins
| ![](/images/4131/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4131/12330_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CDO1 | Cysteine dioxygenase type 1 | Enzymes Predicted intracellular proteins
| | ![](/images/36573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57503/137455_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CLDN5 | Claudin 5 | Predicted membrane proteins
| ![](/images/2607/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2607/6668_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
CLMP | CXADR-like membrane protein | Disease related genes Predicted membrane proteins
| ![](/images/2385/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/2385/8221_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CNTD2 | Cyclin N-terminal domain containing 2 | Predicted intracellular proteins
| ![](/images/45615/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45615/101048_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CNTFR | Ciliary neurotrophic factor receptor | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/25310/ihc_selected_60x60.jpg) | ![](/images/36635/1272_H5_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25310/56429_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CXCL3 | Chemokine (C-X-C motif) ligand 3 | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
DPT | Dermatopontin | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
EBF1 | Early B-cell factor 1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
EBF2 | Early B-cell factor 2 | Predicted intracellular proteins Transcription factors
| ![](/images/37026/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37026/74417_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
EBF3 | Early B-cell factor 3 | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |